Small-molecule modulators of the constitutive androstane receptor

Bibliography

• Baes M, Gulick T, Choi HS, et al. A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol Cell Biol 1994;14:1544–52
   PubMed Web of Science ®Google Scholar
• Wang H, Faucette S, Sueyoshi T, et al. A novel distal enhancer module regulated by pregnane X receptor/constitutive androstane receptor is essential for the maximal induction of CYP2B6 gene expression. J Biol Chem 2003;278:14146–52
   PubMed Web of Science ®Google Scholar
• Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell 1995;83:835–9
   PubMed Web of Science ®Google Scholar
• Min G, Kim H, Bae Y, et al. Inhibitory cross-talk between estrogen receptor (ER) and constitutively activated androstane receptor (CAR). CAR inhibits ER-mediated signaling pathway by squelching p160 coactivators. J Biol Chem 2002;277:34626–33
   PubMed Web of Science ®Google Scholar
• Choi HS, Chung M, Tzameli I, et al. Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR. J Biol Chem 1997;272:23565–71
   PubMed Web of Science ®Google Scholar
• Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell 1995;83:841–50
   PubMed Web of Science ®Google Scholar
• Auerbach SS, Stoner MA, Su S, et al. Retinoid X receptor-alpha-dependent transactivation by a naturally occurring structural variant of human constitutive androstane receptor (NR1I3). Mol Pharmacol 2005;68:1239–53
   PubMed Web of Science ®Google Scholar
• Suino K, Peng L, Reynolds R, et al. The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization. Mol Cell 2004;16:893–905
   PubMed Web of Science ®Google Scholar
• Chen S, Wang K, Wan YJ. Retinoids activate RXR/CAR-mediated pathway and induce CYP3A. Biochem Pharmacol 2010;79:270–6
   PubMed Web of Science ®Google Scholar
• Tzameli I, Pissios P, Schuetz EG, et al. The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR. Mol Cell Biol 2000;20:2951–8
   PubMed Web of Science ®Google Scholar
• Xu RX, Lambert MH, Wisely BB, et al. A structural basis for constitutive activity in the human CAR/RXRalpha heterodimer. Mol Cell 2004;16:919–28
   PubMed Web of Science ®Google Scholar
• Molnar F, Kublbeck J, Jyrkkarinne J, et al. An update on the constitutive androstane receptor (CAR). Drug Metabol Drug Interact 2013;28:79–93
   PubMedGoogle Scholar
• Maglich JM, Parks DJ, Moore LB, et al. Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J Biol Chem 2003;278:17277–83
   PubMed Web of Science ®Google Scholar
• Honkakoski P, Zelko I, Sueyoshi T, et al. The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol Cell Biol 1998;18:5652–8
   PubMed Web of Science ®Google Scholar
• Auerbach SS, Ramsden R, Stoner MA, et al. Alternatively spliced isoforms of the human constitutive androstane receptor. Nucleic Acids Res 2003;31:3194–207
   PubMed Web of Science ®Google Scholar
• Forman BM, Tzameli I, Choi HS, et al. Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta. Nature 1998;395:612–15
   PubMed Web of Science ®Google Scholar
• Burk O, Arnold KA, Nussler AK, et al. Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. Mol Pharmacol 2005;67:1954–65
   PubMed Web of Science ®Google Scholar
• Chen Y, Ferguson SS, Negishi M, et al. Identification of constitutive androstane receptor and glucocorticoid receptor binding sites in the CYP2C19 promoter. Mol Pharmacol 2003;64:316–24
   PubMed Web of Science ®Google Scholar
• Kietzmann T, Hirsch-Ernst KI, Kahl GF, et al. Mimicry in primary rat hepatocyte cultures of the in vivo perivenous induction by phenobarbital of cytochrome P-450 2B1 mRNA: role of epidermal growth factor and perivenous oxygen tension. Mol Pharmacol 1999;56:46–53
   PubMed Web of Science ®Google Scholar
• Waxman DJ, Azaroff L. Phenobarbital induction of cytochrome P-450 gene expression. Biochem J 1992;281(Pt 3):577–92
   PubMed Web of Science ®Google Scholar
• Mutoh S, Sobhany M, Moore R, et al. Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling. Sci Signal 2013;6:ra31
   PubMed Web of Science ®Google Scholar
• Mutoh S, Osabe M, Inoue K, et al. Dephosphorylation of threonine 38 is required for nuclear translocation and activation of human xenobiotic receptor CAR (NR1I3). J Biol Chem 2009;284:34785–92
   PubMed Web of Science ®Google Scholar
• Fernandez AC, Smutny T, Hyrsova L, et al. Chrysin, baicalein and galangin are indirect activators of the human constitutive androstane receptor (CAR). Toxicol Lett 2015;233(2):68–77
   PubMed Web of Science ®Google Scholar
• Lipovsek D. Adnectins: engineered target-binding protein therapeutics. Protein Eng Des Sel 2011;24:3–9
   PubMed Web of Science ®Google Scholar
• Dineen SP, Sullivan LA, Beck AW, et al. The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer. BMC Cancer 2008;8:352
   PubMed Web of Science ®Google Scholar
• Khan JA, Camac DM, Low S, et al. Developing adnectins that target src co-activator binding to PXR: a structural approach toward understanding promiscuity of PXR. J Mol Biol 2015;427:924–42
   PubMed Web of Science ®Google Scholar
• Makinen JM, Frank C, Jyrkkarinne J, et al. Modulation of mouse and human phenobarbital-responsive enhancer module by nuclear receptors. Mol Pharmacol 2002;62:366–78
   PubMed Web of Science ®Google Scholar
• Huang WD, Zhang J, Wei P, et al. Meclizine is an agonist ligand for mouse constitutive androstane receptor (CAR) and an inverse agonist for human CAR. Mol Endocrinol 2004;18:2402–8
   PubMed Web of Science ®Google Scholar
• Lau AJ, Yang GX, Rajaraman G, et al. Differential effect of meclizine on the activity of human pregnane X receptor and constitutive androstane receptor. J Pharmacol Exp Ther 2011;336:816–26
   PubMed Web of Science ®Google Scholar
• Kublbeck J, Jyrkkarinne J, Molnar F, et al. New in vitro tools to study human constitutive androstane receptor (CAR) biology: discovery and comparison of human CAR inverse agonists. Mol Pharm 2011;8:2424–33
   PubMed Web of Science ®Google Scholar
• Moore LB, Parks DJ, Jones SA, et al. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 2000;275:15122–7
   PubMed Web of Science ®Google Scholar
• Toell A, Kroncke KD, Kleinert H, et al. Orphan nuclear receptor binding site in the human inducible nitric oxide synthase promoter mediates responsiveness to steroid and xenobiotic ligands. J Cell Biochem 2002;85:72–82
   PubMed Web of Science ®Google Scholar
• Kublbeck J, Jyrkkarinne J, Poso A, et al. Discovery of substituted sulfonamides and thiazolidin-4-one derivatives as agonists of human constitutive androstane receptor. Biochem Pharmacol 2008;76:1288–97
   PubMed Web of Science ®Google Scholar
• Li LH, Chen T, Stanton JD, et al. The peripheral benzodiazepine receptor ligand 1-(2-chlorophenyl-methylpropyl)-3-isoquinoline-carboxamide is a novel antagonist of human constitutive androstane receptor. Mol Pharmacol 2008;74:443–53
   PubMed Web of Science ®Google Scholar
• Kanno Y, Tanuma N, Takahashi A, et al. T0901317, a potent LXR agonist, is an inverse agonist of CAR. J Toxicol Sci 2013;38:309–15
   PubMed Web of Science ®Google Scholar
• Wang HW, Li H, Moore LB, et al. The phytoestrogen Coumestrol is a naturally occurring antagonist of the human pregnane x receptor. Mol Endocrinol 2008;22:838–57
   PubMed Web of Science ®Google Scholar
• Kanno Y, Tanuma N, Yatsu T, et al. Nigramide J is a novel potent inverse agonist of the human constitutive androstane receptor. Pharma Res Per 2014;2:2
   Google Scholar
• Chen YK, Tang Y, Robbins GT, et al. Camptothecin attenuates cytochrome P450 3A4 induction by blocking the activation of human pregnane X receptor. J Pharmacol Exp Ther 2010;334:999–1008
   PubMed Web of Science ®Google Scholar
• Krausova L, Stejskaova L, Wang HW, et al. Metformin suppresses pregnane X receptor (PXR)-regulated transactivation of CYP3A4 gene. Biochem Pharmacol 2011;82:1771–80
   PubMed Web of Science ®Google Scholar
• Lim YP, Cheng CH, Chen WC, et al. Allyl isothiocyanate (AITC) inhibits pregnane X receptor (PXR) and constitutive androstane receptor (CAR) activation and protects against acetaminophen- and amiodarone-induced cytotoxicity. Arch Toxicol 2015;89:57–72
   PubMed Web of Science ®Google Scholar
• Huang H, Wang H, Sinz M, et al. Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole. Oncogene 2007;26:258–68
   PubMed Web of Science ®Google Scholar
• Ingraham HA, Redinbo MR. Orphan nuclear receptors adopted by crystallography. Curr Opin Struct Biol 2005;15:708–15
   PubMed Web of Science ®Google Scholar
• Xu RX, Lambert MH, Wisely BB, et al. A structural basis for constitutive activity in the human CAR/RXR alpha heterodimer. Mol Cell 2004;16:919–28
   PubMed Web of Science ®Google Scholar
• Suino K, Peng L, Reynolds R, et al. The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization. Mol Cell 2004;16:893–905
   PubMed Web of Science ®Google Scholar
• Shan L, Vincent J, Brunzelle JS, et al. Structure of the murine constitutive androstane receptor complexed to androstenol: a molecular basis for inverse agonism. Mol Cell 2004;16:907–17
   PubMed Web of Science ®Google Scholar
• Shmueli O, Horn-Saban S, Chalifa-Caspi V, et al. GeneNote: whole genome expression profiles in normal human tissues. C R Biol 2003;326:1067–72
   PubMed Web of Science ®Google Scholar
• Lamba JK, Lamba V, Yasuda K, et al. Expression of constitutive androstane receptor splice variants in human tissues and their functional consequences. J Pharmacol Exp Ther 2004;311:811–21
   PubMed Web of Science ®Google Scholar
• Arnold KA, Eichelbaum M, Burk O. Alternative splicing affects the function and tissue-specific expression of the human constitutive androstane receptor. Nucl Recept 2004;2:1
   PubMedGoogle Scholar
• GeneCards: NR1I3 gene. Available from: http://www.genecards.org/cgi-bin/carddisp.pl?gene=NR1I3 [Last updated on 7 May 2014, Cited on 7 April 2015]
   Google Scholar
• Auerbach SS, Dekeyser JG, Stoner MA, et al. CAR2 displays unique ligand binding and RXRalpha heterodimerization characteristics. Drug Metab Dispos 2007;35:428–39
   PubMed Web of Science ®Google Scholar
• Kanno Y, Aoki S, Nakahama T, et al. Role of the defective splicing of mRNA in the lack of pulmonary expression of constitutively active receptor in rat. J Health Sci 2003;49:541–6
   Web of Science ®Google Scholar
• Omiecinski CJ, Coslo DM, Chen T, et al. Multi-species analyses of direct activators of the constitutive androstane receptor. Toxicol Sci 2011;123:550–62
   PubMed Web of Science ®Google Scholar
• Ikeda S, Kurose K, Jinno H, et al. Functional analysis of four naturally occurring variants of human constitutive androstane receptor. Mol Genet Metab 2005;86:314–19
   PubMed Web of Science ®Google Scholar
• Lau AJ, Chang TK. Fetal bovine serum and human constitutive androstane receptor: evidence for activation of the SV23 splice variant by artemisinin, artemether, and arteether in a serum-free cell culture system. Toxicol Appl Pharmacol 2014;277:221–30
   PubMed Web of Science ®Google Scholar
• Sharma D, Lau AJ, Sherman MA, et al. Differential activation of human constitutive androstane receptor and its SV23 and SV24 splice variants by rilpivirine and etravirine. Br J Pharmacol 2014;172(5):1263–76
   Web of Science ®Google Scholar
• Jinno H, Tanaka-Kagawa T, Hanioka N, et al. Identification of novel alternative splice variants of human constitutive androstane receptor and characterization of their expression in the liver. Mol Pharmacol 2004;65:496–502
   PubMed Web of Science ®Google Scholar
• Choi EJ, Jang YJ, Cha EY, et al. Identification and characterization of novel alternative splice variants of human constitutive androstane receptor in liver samples of Koreans and Caucasians. Drug Metab Dispos 2013;41:888–96
   PubMed Web of Science ®Google Scholar
• Cortes CP, Siccardi M, Chaikan A, et al. Correlates of efavirenz exposure in Chilean patients affected with human immunodeficiency virus reveals a novel association with a polymorphism in the constitutive androstane receptor. Ther Drug Monit 2013;35:78–83
   PubMed Web of Science ®Google Scholar
• Urano T, Usui T, Shiraki M, et al. Association of a single nucleotide polymorphism in the constitutive androstane receptor gene with bone mineral density. Geriatr Gerontol Int 2009;9:235–41
   PubMed Web of Science ®Google Scholar
• Ding X, Lichti K, Kim I, et al. Regulation of constitutive androstane receptor and its target genes by fasting, cAMP, hepatocyte nuclear factor alpha, and the coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha. J Biol Chem 2006;281:26540–51
   PubMed Web of Science ®Google Scholar
• Tirona RG, Lee W, Leake BF, et al. The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nat Med 2003;9:220–4
   PubMed Web of Science ®Google Scholar
• Pascussi JM, Gerbal-Chaloin S, Fabre JM, et al. Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation. Mol Pharmacol 2000;58:1441–50
   PubMed Web of Science ®Google Scholar
• Goodwin B, Hodgson E, D’Costa DJ, et al. Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor. Mol Pharmacol 2002;62:359–65
   PubMed Web of Science ®Google Scholar
• Li L, Chen T, Stanton JD, et al. The peripheral benzodiazepine receptor ligand 1-(2-chlorophenyl-methylpropyl)-3-isoquinoline-carboxamide is a novel antagonist of human constitutive androstane receptor. Mol Pharmacol 2008;74:443–53
   PubMed Web of Science ®Google Scholar
• Kohalmy K, Tamasi V, Kobori L, et al. Dehydroepiandrosterone induces human CYP2B6 through the constitutive androstane receptor. Drug Metab Dispos 2007;35:1495–501
   PubMed Web of Science ®Google Scholar
• Kawamoto T, Kakizaki S, Yoshinari K, et al. Estrogen activation of the nuclear orphan receptor CAR (constitutive active receptor) in induction of the mouse Cyp2b10 gene. Mol Endocrinol 2000;14:1897–905
   PubMed Web of Science ®Google Scholar
• Makinen J, Reinisalo M, Niemi K, et al. Dual action of oestrogens on the mouse constitutive androstane receptor. Biochem J 2003;376:465–72
   PubMed Web of Science ®Google Scholar
• Koh KH, Jurkovic S, Yang K, et al. Estradiol induces cytochrome P450 2B6 expression at high concentrations: implication in estrogen-mediated gene regulation in pregnancy. Biochem Pharmacol 2012;84:93–103
   PubMed Web of Science ®Google Scholar
• Masuyama H, Hiramatsu Y. Potential role of estradiol and progesterone in insulin resistance through constitutive androstane receptor. J Mol Endocrinol 2011;47:229–39
   PubMed Web of Science ®Google Scholar
• Min G, Kemper JK, Kemper B. Glucocorticoid receptor-interacting protein 1 mediates ligand-independent nuclear translocation and activation of constitutive androstane receptor in vivo. J Biol Chem 2002;277:26356–63
   PubMed Web of Science ®Google Scholar
• Sugatani J, Sueyoshi T, Negishi M, et al. Regulation of the human UGT1A1 Gene by nuclear receptors constitutive active/androstane receptor, pregnane X receptor, and glucocorticoid receptor. In: Helmut S, Lester P, editors. Methods enzymol. Academic Press, Waltham, Massachusetts; 2005. p. 92–104
   Google Scholar
• Fang HL, Strom SC, Cai H, et al. Regulation of human hepatic hydroxysteroid sulfotransferase gene expression by the peroxisome proliferator-activated receptor alpha transcription factor. Mol Pharmacol 2005;67:1257–67
   PubMed Web of Science ®Google Scholar
• Maglich JM, Watson J, McMillen PJ, et al. The nuclear receptor CAR is a regulator of thyroid hormone metabolism during caloric restriction. J Biol Chem 2004;279:19832–8
   PubMed Web of Science ®Google Scholar
• Qatanani M, Zhang J, Moore DD. Role of the constitutive androstane receptor in xenobiotic-induced thyroid hormone metabolism. Endocrinology 2005;146:995–1002
   PubMed Web of Science ®Google Scholar
• Kiyosawa N, Tanaka K, Hirao J, et al. Molecular mechanism investigation of phenobarbital-induced serum cholesterol elevation in rat livers by microarray analysis. Arch Toxicol 2004;78:435–42
   PubMed Web of Science ®Google Scholar
• Ueda A, Hamadeh HK, Webb HK, et al. Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. Mol Pharmacol 2002;61:1–6
   PubMed Web of Science ®Google Scholar
• Lynch C, Pan Y, Li L, et al. Activation of the constitutive androstane receptor inhibits gluconeogenesis without affecting lipogenesis or fatty acid synthesis in human hepatocytes. Toxicol Appl Pharmacol 2014;279:33–42
   PubMed Web of Science ®Google Scholar
• Roth A, Looser R, Kaufmann M, et al. Regulatory cross-talk between drug metabolism and lipid homeostasis: constitutive androstane receptor and pregnane X receptor increase Insig-1 expression. Mol Pharmacol 2008;73:1282–9
   PubMed Web of Science ®Google Scholar
• Gao J, He J, Zhai Y, et al. The constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity. J Biol Chem 2009;284:25984–92
   PubMed Web of Science ®Google Scholar
• Tamashiro KL, Terrillion CE, Hyun J, et al. Prenatal stress or high-fat diet increases susceptibility to diet-induced obesity in rat offspring. Diabetes 2009;58:1116–25
   PubMed Web of Science ®Google Scholar
• Dong B, Qatanani M, Moore DD. Constitutive androstane receptor mediates the induction of drug metabolism in mouse models of type 1 diabetes. Hepatology 2009;50:622–9
   PubMed Web of Science ®Google Scholar
• Dong B, Saha PK, Huang W, et al. Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease. Proc Natl Acad Sci USA 2009;106:18831–6
   PubMed Web of Science ®Google Scholar
• Huang W, Zhang J, Chua SS, et al. Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc Natl Acad Sci USA 2003;100:4156–61
   PubMed Web of Science ®Google Scholar
• Kast HR, Goodwin B, Tarr PT, et al. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 2002;277:2908–15
   PubMed Web of Science ®Google Scholar
• Sugatani J, Kojima H, Ueda A, et al. The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology 2001;33:1232–8
   PubMed Web of Science ®Google Scholar
• Guo GL, Lambert G, Negishi M, et al. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J Biol Chem 2003;278:45062–71
   PubMed Web of Science ®Google Scholar
• Saini SP, Sonoda J, Xu L, et al. A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification. Mol Pharmacol 2004;65:292–300
   PubMed Web of Science ®Google Scholar
• Zhang J, Huang W, Qatanani M, et al. The constitutive androstane receptor and pregnane X receptor function coordinately to prevent bile acid-induced hepatotoxicity. J Biol Chem 2004;279:49517–22
   PubMed Web of Science ®Google Scholar
• Stedman CA, Liddle C, Coulter SA, et al. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury. Proc Natl Acad Sci U S A 2005;102:2063–8
   PubMed Web of Science ®Google Scholar
• Peraino C, Fry RJ, Staffeldt E. Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene. Cancer Res 1971;31:1506–12
   PubMed Web of Science ®Google Scholar
• Nishizumi M. Enhancement of diethylnitrosamine hepatocarcinogenesis in rats by exposure to polychlorinated biphenyls or phenobarbital. Cancer Lett 1976;2:11–15
   PubMed Web of Science ®Google Scholar
• Huang W, Zhang J, Washington M, et al. Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol Endocrinol 2005;19:1646–53
   PubMed Web of Science ®Google Scholar
• Ward JM. Increased susceptibility of livers of aged F344/NCr rats to the effects of phenobarbital on the incidence, morphology, and histochemistry of hepatocellular foci and neoplasms. J Natl Cancer Inst 1983;71:815–23
   PubMed Web of Science ®Google Scholar
• Ward JM, Rice JM, Creasia D, et al. Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice. Carcinogenesis 1983;4:1021–9
   PubMed Web of Science ®Google Scholar
• Diwan BA, Rice JM, Ohshima M, et al. Interstrain differences in susceptibility to liver carcinogenesis initiated by N-nitrosodiethylamine and its promotion by phenobarbital in C57BL/6NCr, C3H/HeNCrMTV- and DBA/2NCr mice. Carcinogenesis 1986;7:215–20
   PubMed Web of Science ®Google Scholar
• Kodama S, Negishi M. Phenobarbital confers its diverse effects by activating the orphan nuclear receptor car. Drug Metab Rev 2006;38:75–87
   PubMed Web of Science ®Google Scholar
• Tinwell H, Rouquié D, Schorsch F, et al. Liver tumor formation in female rat induced by fluopyram is mediated by CAR/PXR nuclear receptor activation. Regul Toxicol Pharmacol 2015;70(3):648–58
   Web of Science ®Google Scholar
• Ledda-Columbano GM, Pibiri M, Concas D, et al. Sex difference in the proliferative response of mouse hepatocytes to treatment with the CAR ligand. Carcinogenesis 2003;24:1059–65
   PubMed Web of Science ®Google Scholar
• Takizawa D, Kakizaki S, Horiguchi N, et al. Constitutive active/androstane receptor promotes hepatocarcinogenesis in a mouse model of non-alcoholic steatohepatitis. Carcinogenesis 2011;32:576–83
   PubMed Web of Science ®Google Scholar
• Yueh M-F, Li T, Evans RM, et al. Triclocarban Mediates Induction of Xenobiotic Metabolism through Activation of the Constitutive Androstane Receptor and the Estrogen Receptor Alpha. PLoS ONE 2012;7:e37705
   PubMed Web of Science ®Google Scholar
• Yueh M-F, Taniguchi K, Chen S, et al. The commonly used antimicrobial additive triclosan is a liver tumor promoter. Proc Natl Acad Sci 2014;111:17200–5
   PubMed Web of Science ®Google Scholar
• Yamada T, Uwagawa S, Okuno Y, et al. Case study: an evaluation of the human relevance of the synthetic pyrethroid metofluthrin-induced liver tumors in rats based on mode of action. Toxicol Sci 2009;108:59–68
   PubMed Web of Science ®Google Scholar
• Peffer RC, Moggs JG, Pastoor T, et al. Mouse liver effects of cyproconazole, a triazole fungicide: role of the constitutive androstane receptor. Toxicol Sci 2007;99:315–25
   PubMed Web of Science ®Google Scholar
• Deguchi Y, Yamada T, Hirose Y, et al. Mode of action analysis for the synthetic pyrethroid metofluthrin-induced rat liver tumors: evidence for hepatic CYP2B induction and hepatocyte proliferation. Toxicol Sci 2009;108:69–80
   PubMed Web of Science ®Google Scholar
• Currie RA, Peffer RC, Goetz AK, et al. Phenobarbital and propiconazole toxicogenomic profiles in mice show major similarities consistent with the key role that constitutive androstane receptor (CAR) activation plays in their mode of action. Toxicology 2014;321:80–8
   PubMed Web of Science ®Google Scholar
• Morita R, Yafune A, Shiraki A, et al. Liver tumor promoting effect of orphenadrine in rats and its possible mechanism of action including CAR activation and oxidative stress. J Toxicol Sci 2013;38:403–13
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Moore R, Goldsworthy TL, et al. The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res 2004;64:7197–200
   PubMed Web of Science ®Google Scholar
• Lamminpaa A, Pukkala E, Teppo L, et al. Cancer incidence among patients using antiepileptic drugs: a long-term follow-up of 28,000 patients. Eur J Clin Pharmacol 2002;58:137–41
   PubMed Web of Science ®Google Scholar
• Olsen JH, Schulgen G, Boice JDJr, et al. Antiepileptic treatment and risk for hepatobiliary cancer and malignant lymphoma. Cancer Res 1995;55:294–7
   PubMed Web of Science ®Google Scholar
• Lake BG. Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation. Xenobiotica 2009;39:582–96
   PubMed Web of Science ®Google Scholar
• Yamada T, Okuda Y, Kushida M, et al. Human hepatocytes support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogen sodium phenobarbital in an in vivo study using a chimeric mouse with humanized liver. Toxicol Sci 2014;142:137–57
   PubMed Web of Science ®Google Scholar
• Phillips JM, Goodman JI. Multiple Genes Exhibit Phenobarbital-Induced Constitutive Active/Androstane Receptor–Mediated DNA Methylation Changes during Liver Tumorigenesis and in Liver Tumors. Toxicol Sci 2009;108:273–89
   PubMed Web of Science ®Google Scholar
• Luisier R, Lempiainen H, Scherbichler N, et al. Phenobarbital induces cell cycle transcriptional responses in mouse liver humanized for constitutive androstane and pregnane x receptors. Toxicol Sci 2014;139:501–11
   PubMed Web of Science ®Google Scholar
• Braeuning A, Gavrilov A, Brown S, et al. Phenobarbital-mediated tumor promotion in transgenic mice with humanized CAR and PXR. Toxicol Sci 2014;140:259–70
   PubMed Web of Science ®Google Scholar
• Ross J, Plummer SM, Rode A, et al. Human constitutive androstane receptor (CAR) and pregnane X receptor (PXR) support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogens phenobarbital and chlordane in vivo. Toxicol Sci 2010;116:452–66
   PubMed Web of Science ®Google Scholar
• Elcombe CR, Peffer RC, Wolf DC, et al. Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activator. Crit Rev Toxicol 2014;44:64–82
   PubMed Web of Science ®Google Scholar
• Hirose Y, Nagahori H, Yamada T, et al. Comparison of the effects of the synthetic pyrethroid Metofluthrin and phenobarbital on CYP2B form induction and replicative DNA synthesis in cultured rat and human hepatocytes. Toxicology 2009;258:64–9
   PubMed Web of Science ®Google Scholar
• Li H, Wang H. Activation of xenobiotic receptors: driving into the nucleus. Expert Opin Drug Metab Toxicol 2010;6:409–26
   PubMed Web of Science ®Google Scholar
• Holsapple MP, Pitot HC, Cohen SH, et al. Mode of Action in Relevance of Rodent Liver Tumors to Human Cancer Risk. Toxicol Sci 2006;89:51–6
   PubMed Web of Science ®Google Scholar
• Wang D, Li L, Yang H, et al. The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignancies. Blood 2013;121:329–38
   PubMed Web of Science ®Google Scholar
• Fukumasu H, Rochetti AL, Pires PR, et al. Constitutive androstane receptor ligands modulate the anti-tumor efficacy of paclitaxel in non-small cell lung cancer cells. PLoS ONE 2014;9:e99484
   PubMedGoogle Scholar
• Nallani SC, Goodwin B, Maglich JM, et al. Induction of cytochrome P450 3A by paclitaxel in mice: pivotal role of the nuclear xenobiotic receptor, pregnane X receptor. Drug Metab Dispos 2003;31:681–4
   PubMed Web of Science ®Google Scholar
• Harmsen S, Meijerman I, Febus CL, et al. PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell line. Cancer Chemother Pharmacol 2010;66:765–71
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Kanakasabai S, Bright JJ. Constitutive androstane receptor agonist CITCO inhibits growth and expansion of brain tumour stem cells. Br J Cancer 2011;104:448–59
   PubMed Web of Science ®Google Scholar
• Wang Y, Masuyama H, Nobumoto E, et al. The inhibition of constitutive androstane receptor-mediated pathway enhances the effects of anticancer agents in ovarian cancer cells. Biochem Pharmacol 2014;90:356–66
   PubMed Web of Science ®Google Scholar
• Chen WD, Fu X, Dong B, et al. Neonatal activation of the nuclear receptor CAR results in epigenetic memory and permanent change of drug metabolism in mouse liver. Hepatology 2012;56:1499–509
   PubMed Web of Science ®Google Scholar
• Chen F, Zamule SM, Coslo DM, et al. The human constitutive androstane receptor promotes the differentiation and maturation of hepatic-like cells. Dev Biol 2013;384:155–65
   PubMed Web of Science ®Google Scholar
• Goerdt C, Keith M, Rubins HB. Effects of Phenytoin on Plasma High-Density Lipoprotein Cholesterol Levels in Men with Low Levels of High-Density Lipoprotein Cholesterol. J Clin Pharmacol 1995;35:767–75
   PubMed Web of Science ®Google Scholar
• Pelkonen R, Fogelholm R, Nikkila EA. Increase in serum cholesterol during phenytoin treatment. Br Med J 1975;4:85
   PubMed Web of Science ®Google Scholar
• Masson D, Qatanani M, Sberna AL, et al. Activation of the constitutive androstane receptor decreases HDL in wild-type and human apoA-I transgenic mice. J Lipid Res 2008;49:1682–91
   PubMed Web of Science ®Google Scholar
• Cherian MT, Lin W, Wu J, et al. CINPA1 is an inhibitor of constitutive androstane receptor that does not activate pregnane X receptor. Mol Pharmacol 2015;87:878–89
   PubMed Web of Science ®Google Scholar
• Zhang J, Huang W, Chua SS, et al. Modulation of Acetaminophen-Induced Hepatotoxicity by the Xenobiotic Receptor CAR. Science 2002;298:422–4
   PubMed Web of Science ®Google Scholar
• Li L, Hassan HE, Tolson AH, et al. Differential activation of pregnane X receptor and constitutive androstane receptor by buprenorphine in primary human hepatocytes and HepG2 cells. J Pharmacol Exp Ther 2010;335:562–71
   PubMed Web of Science ®Google Scholar
• Sueyoshi T, Kawamoto T, Zelko I, et al. The repressed nuclear receptor car responds to phenobarbital in activating the human CYP2B6 gene. J Biol Chem 1999;274:6043–6
   PubMed Web of Science ®Google Scholar
• Wang H, Faucette S, Moore R, et al. Human constitutive androstane receptor mediates induction of CYP2B6 gene expression by phenytoin. J Biol Chem 2004;279:29295–301
   PubMed Web of Science ®Google Scholar
• Faucette SR, Zhang TC, Moore R, et al. Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers. J Pharmacol Exp Ther 2007;320:72–80
   PubMed Web of Science ®Google Scholar
• Cerveny L, Svecova L, Anzenbacherova E, et al. Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways. Drug Metab Dispos 2007;35:1032–41
   PubMed Web of Science ®Google Scholar
• Wei P, Zhang J, Dowhan DH, et al. Specific and overlapping functions of the nuclear hormone receptors CAR and PXR in xenobiotic response. Pharmacogenomics J 2002;2:117–26
   PubMedGoogle Scholar
• Meyer zu Schwabedissen HE, Oswald S, Bresser C, et al. Compartment-specific gene regulation of the CAR inducer efavirenz in vivo. Clin Pharmacol Ther 2012;92:103–11
   PubMed Web of Science ®Google Scholar
• Sharma D, Lau AJ, Sherman MA, et al. Agonism of human pregnane X receptor by rilpivirine and etravirine: comparison with first generation non-nucleoside reverse transcriptase inhibitors. Biochem Pharmacol 2013;85:1700–11
   PubMed Web of Science ®Google Scholar
• Wang D, Li L, Fuhrman J, et al. The role of constitutive androstane receptor in oxazaphosphorine-mediated induction of drug-metabolizing enzymes in human hepatocytes. Pharm Res 2011;28:2034–44
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Yamanaka Y, Iwazaki N, et al. Identification of HMG-CoA reductase inhibitors as activators for human, mouse and rat constitutive androstane receptor. Drug Metab Dispos 2005;33:924–9
   PubMed Web of Science ®Google Scholar
• Mnif W, Pascussi JM, Pillon A, et al. Estrogens and antiestrogens activate hPXR. Toxicol Lett 2007;170:19–29
   PubMed Web of Science ®Google Scholar
• Repo S, Jyrkkarinne J, Pulkkinen JT, et al. Ligand specificity of constitutive androstane receptor as probed by induced-fit docking and mutagenesis. J Med Chem 2008;51:7119–31
   PubMed Web of Science ®Google Scholar
• Ripp SL, Fitzpatrick JL, Peters JM, et al. Induction of CYP3A expression by dehydroepiandrosterone: involvement of the pregnane X receptor. Drug Metab Dispos 2002;30:570–5
   PubMed Web of Science ®Google Scholar
• Moore LB, Parks DJ, Jones SA, et al. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 2000;275:15122–7
   PubMed Web of Science ®Google Scholar
• Lemaire G, de Sousa G, Rahmani R. A PXR reporter gene assay in a stable cell culture system: CYP3A4 and CYP2B6 induction by pesticides. Biochem Pharmacol 2004;68:2347–58
   PubMed Web of Science ®Google Scholar
• Li L, Stanton J, Tolson A, et al. Bioactive terpenoids and flavonoids from ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane x receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways. Pharm Res 2009;26:872–82
   PubMed Web of Science ®Google Scholar
• Yao R, Yasuoka A, Kamei A, et al. Dietary flavonoids activate the constitutive androstane receptor (CAR). J Agric Food Chem 2010;58:2168–73
   PubMed Web of Science ®Google Scholar
• Sugatani J, Yamakawa K, Tonda E, et al. The induction of human UDP-glucuronosyltransferase 1A1 mediated through a distal enhancer module by flavonoids and xenobiotics. Biochem Pharmacol 2004;67:989–1000
   PubMed Web of Science ®Google Scholar
• Hiura Y, Satsu H, Hamada M, et al. Analysis of flavonoids regulating the expression of UGT1A1 via xenobiotic receptors in intestinal epithelial cells. Biofactors 2014;40:336–45
   PubMed Web of Science ®Google Scholar
• Fisher CD, Augustine LM, Maher JM, et al. Induction of drug-metabolizing enzymes by garlic and allyl sulfide compounds via activation of constitutive androstane receptor and nuclear factor E2-related factor 2. Drug Metab Dispos 2007;35:995–1000
   PubMed Web of Science ®Google Scholar
• Yao R, Yasuoka A, Kamei A, et al. Polyphenols in alcoholic beverages activating constitutive androstane receptor CAR. Biosci Biotechnol Biochem 2011;75:1635–7
   PubMed Web of Science ®Google Scholar
• Kocarek TA, Mercer-Haines NA. Squalestatin 1-inducible expression of rat CYP2B: evidence that an endogenous isoprenoid is an activator of the constitutive androstane receptor. Mol Pharmacol 2002;62:1177–86
   PubMed Web of Science ®Google Scholar
• Lau AJ, Yang G, Rajaraman G, et al. Species-dependent and receptor-selective action of bilobalide on the function of constitutive androstane receptor and pregnane X receptor. Drug Metab Dispos 2012;40:178–86
   PubMed Web of Science ®Google Scholar
• Paul KB, Thompson JT, Simmons SO, et al. Evidence for triclosan-induced activation of human and rodent xenobiotic nuclear receptors. Toxicol In Vitro 2013;27:2049–60
   PubMed Web of Science ®Google Scholar
• Kiyosawa N, Kwekel JC, Burgoon LD, et al. Species-specific regulation of PXR/CAR/ER-target genes in the mouse and rat liver elicited by o, p’-DDT. BMC Genomics 2008;9:487
   PubMed Web of Science ®Google Scholar
• Kiyosawa N, Kwekel JC, Burgoon LD, et al. o,p’-DDT elicits PXR/CAR-, not ER-, mediated responses in the immature ovariectomized rat liver. Toxicol Sci 2008;101:350–63
   PubMed Web of Science ®Google Scholar
• Kublbeck J, Laitinen T, Jyrkkarinne J, et al. Use of comprehensive screening methods to detect selective human CAR activators. Biochem Pharmacol 2011;82:1994–2007
   PubMed Web of Science ®Google Scholar
• Blizard D, Sueyoshi T, Negishi M, et al. Mechanism of induction of cytochrome p450 enzymes by the proestrogenic endocrine disruptor pesticide-methoxychlor: interactions of methoxychlor metabolites with the constitutive androstane receptor system. Drug Metab Dispos 2001;29:781–5
   PubMed Web of Science ®Google Scholar
• Savary CC, Josse R, Bruyere A, et al. Interactions of endosulfan and methoxychlor involving CYP3A4 and CYP2B6 in human HepaRG cells. Drug Metab Dispos 2014;42:1235–40
   PubMed Web of Science ®Google Scholar
• Mikamo E, Harada S, Nishikawa J, et al. Endocrine disruptors induce cytochrome P450 by affecting transcriptional regulation via pregnane X receptor. Toxicol Appl Pharmacol 2003;193:66–72
   PubMed Web of Science ®Google Scholar
• Lemaire G, Mnif W, Pascussi JM, et al. Identification of new human pregnane X receptor ligands among pesticides using a stable reporter cell system. Toxicol Sci 2006;91:501–9
   PubMed Web of Science ®Google Scholar
• Price RJ, Walters DG, Finch JM, et al. A mode of action for induction of liver tumors by Pyrethrins in the rat. Toxicol Appl Pharmacol 2007;218:186–95
   PubMed Web of Science ®Google Scholar
• LeBaron MJ, Geter DR, Rasoulpour RJ, et al. An integrated approach for prospectively investigating a mode-of-action for rodent liver effects. Toxicol Appl Pharmacol 2013;270:164–73
   PubMed Web of Science ®Google Scholar
• DeKeyser JG, Stagliano MC, Auerbach SS, et al. Di(2-ethylhexyl) phthalate is a highly potent agonist for the human constitutive androstane receptor splice variant CAR2. Mol Pharmacol 2009;75:1005–13
   PubMed Web of Science ®Google Scholar
• Tamura K, Inoue K, Takahashi M, et al. Involvement of constitutive androstane receptor in liver hypertrophy and liver tumor development induced by triazole fungicides. Food Chem Toxicol 2015;78:86–95
   PubMed Web of Science ®Google Scholar
• Honkakoski P, Palvimo JJ, Penttila L, et al. Effects of triaryl phosphates on mouse and human nuclear receptors. Biochem Pharmacol 2004;67:97–106
   PubMed Web of Science ®Google Scholar